Next-generation sequencing: insights to advance clinical investigations of the microbiome

CR Wensel, JL Pluznick, SL Salzberg… - The Journal of clinical …, 2022 - Am Soc Clin Investig
Next-generation sequencing (NGS) technology has advanced our understanding of the
human microbiome by allowing for the discovery and characterization of unculturable …

Microbiota succession throughout life from the cradle to the grave

C Martino, AH Dilmore, ZM Burcham… - Nature Reviews …, 2022 - nature.com
Associations between age and the human microbiota are robust and reproducible. The
microbial composition at several body sites can predict human chronological age relatively …

SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection

P Feuerstadt, TJ Louie, B Lashner… - … England Journal of …, 2022 - Mass Medical Soc
Background Current therapies for recurrent Clostridioides difficile infection do not address
the disrupted microbiome, which supports C. difficile spore germination into toxin-producing …

Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a Bayesian primary analysis for the prevention of …

S Khanna, M Assi, C Lee, D Yoho, T Louie, W Knapple… - Drugs, 2022 - Springer
Abstract Background Recurrent Clostridioides difficile infection, associated with dysbiosis of
gut microbiota, has substantial disease burden in the USA. RBX2660 is a live biotherapeutic …

ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease

T Kucharzik, P Ellul, T Greuter, JF Rahier… - Journal of Crohn's …, 2021 - academic.oup.com
The introduction and broad use of new immunosuppressive agents, including biologic
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …

Gut microbiota influence in type 2 diabetes mellitus (T2DM)

AL Cunningham, JW Stephens, DA Harris - Gut Pathogens, 2021 - Springer
A strong and expanding evidence base supports the influence of gut microbiota in human
metabolism. Altered glucose homeostasis is associated with altered gut microbiota, and is …

Problems with the concept of gut microbiota dysbiosis

H Brüssow - Microbial biotechnology, 2020 - Wiley Online Library
The human microbiome research is with the notable exception of fecal transplantation still
mostly in a descriptive phase. Part of the difficulty for translating research into medical …

Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology

A Khoruts, C Staley, MJ Sadowsky - Nature Reviews Gastroenterology & …, 2021 - nature.com
Faecal microbiota transplantation (FMT) has emerged as a remarkably successful treatment
for recurrent Clostridioides difficile infection that cannot be cured with antibiotics alone …

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical …

R Orenstein, ER Dubberke, S Khanna, CH Lee… - BMC infectious …, 2022 - Springer
Background Effective treatment options for recurrent Clostridioides difficile infection (rCDI)
are limited, with high recurrence rates associated with the current standard of care. Herein …

Probiotics, prebiotics, synbiotics, and fecal microbiota transplantation in the treatment of behavioral symptoms of autism spectrum disorder: A systematic review

Q Tan, CE Orsso, EC Deehan, JY Kung… - Autism …, 2021 - Wiley Online Library
The emerging role of a microbiota‐gut‐brain axis in autism spectrum disorder (ASD)
suggests that modulating gut microbial composition may offer a tractable approach to …